Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

NCT00593450 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1208

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: ranibizumab
DRUG: bevacizumab

Sponsor

University of Pennsylvania

Collaborators

[object Object]